Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0024530 (malaria)
 44,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Monoclonal antibodies (MAbs) which are reactive with several antigenically distinct variable antigen types were prepared by immunization with Trypanosoma brucei rhodesiense. Certain MAbs were shown to be specific for members of the genus Trypanosoma and not reactive with Leishmania spp. or Plasmodium falciparum by the indirect immunofluorescence assay. These genus-specific MAbs were used to identify the molecular location of these invariant antigen determinants in whole T. brucei rhodesiense antigen preparations. Two monoclonals reacted with a low-molecular-weight doublet of approximately 22,000 relative molecular weight on Western blots of whole trypanosome antigen preparations separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These determinants did not appear to be on the variable surface glycoprotein molecule and were destroyed by trypsin digestion. Binding studies in which live, DEAE-purified, bloodstream trypanosomes were exposed to invariant antigen-specific MAbs suggested these determinants were accessible on living trypanosomes. Genus-specific MAbs also reacted with determinants present in sera from African trypanosomiasis patients in a dot immunobinding assay but not sera from patients with malaria or leishmaniasis. These results suggest that certain invariant molecules of African trypanosomes are immunogenic, possibly accessible on the trypanosome surface, and may be present as circulating invariant antigen in trypanosomiasis patients.
 ...
PMID:Molecular identity and location of invariant antigens on Trypanosoma brucei rhodesiense defined with monoclonal antibodies reactive with sera from trypanosomiasis patients. 390 17

This paper offers a quantitative evaluation of the scientific information produced in Brazil on several endemic diseases: Chagas' disease, schistosomiasis, leishmaniasis, leprosy, malaria and filariasis. The source of data was the Index Medicus Latino Americano (IMLA), and the published scientific information was analyzed in general and specifically, by type of disease and year of publication. The indexed production of articles on the material of the Latin American countries as a whole increased from 3,506 articles in 1978 to 5,528 in 1982 (for an increase of 52.7%), whereas that of Brazil alone rose from 1,781 to 2,531 (an increase of 42.1%) during the same period. The output of articles on endemic diseases totaled 703 papers (6.3% of the total indexed production). Of this total, 441 (62.7%) was on applied research and 262 (37.3%) were on basic research, and these proportions held relatively constant. Chagas' disease and schistosomiasis accounted for 75.2% of that total over the period considered. The production of papers on the diseases of interest grew 79.2%, at the same rate as that of all biomedical information published in Brazil over the period. An equilibrium was reached between the numbers of basic and applied papers. The analysis also identified the core of Brazilian periodicals that most frequently publish information on those endemics. It was also found that a large proportion of articles by Brazilian authors are published in journals of international circulation, and the foreign journals that publish papers by researchers in Brazil were identified.
 ...
PMID:[Analysis of scientific information published in Brazil in 5 years on Chagas disease, schistosomiasis, malaria, leishmaniasis and filariasis]. 392 29

The tropical splenomegaly syndrome, described by Charmot as a chronic splenomegaly without any acute malaria attack, appears to be the prototype of hyperimmune malaria. A very small number of red cells or even no red cells are infected. IgG and/or IgM rates are greatly increased, as are anti-Plasmodium antibodies. The ratio T. helper/T. suppressor is normal or slightly increased. Serological tests show often cross reactions, mainly with African trypanosomiasis and toxoplasmosis, also with leishmaniasis. Undefined genetic factors in the host could explain the syndrome.
 ...
PMID:[Cellular and humoral immunity in hyperimmune malaria]. 393 94

A questionnaire inquiring into the nature of schemes for the insecticidal control of disease vectors, the development of resistance in these vectors, and the effect of any such resistance on their control and on the extent of disease was sent to more than 100 health authorities throughout the world. The replies to the questionnaire are summarized in this paper.Until recently, the use of insecticides in public health has been largely based on three organochlorine compounds-DDT, HCH and dieldrin. However, in some countries resistance to these has now severely affected control both of many insect species and of the diseases they transmit (e.g., malaria, yellow fever, filariasis, typhus, plague). Certain other public health problems (onchocerciasis, Chagas' disease, trypanosomiasis, leishmaniasis) have not so far been greatly affected by resistance, but it is difficult to be sure of the continued reliability of the organochlorines.Research in the past 5 years, much of it sponsored by WHO, has shown the value of various organophosphorus and carbamate insecticides as replacements for the organochlorines, although resistance to them, too, can occur. Attention must therefore be focused on all facets of the use of these newer compounds and particular scrutiny made of possible instances of resistance to them.
 ...
PMID:The impact of insecticide-resistance on control of vectors and vector-borne diseases. 530 34

A case of laryngeal leishmaniasis in a patient living in eastern France is reported. Mucosal leishmaniasis appears to be frequent in the New World but rare in the Old World, where only 9 cases have been published, including 3 from France. In this particular patient, there probably was some relationship between the laryngeal lesion and an unexplained malaria-like fever contracted in Algeria 19 years before. This case provides evidence that leishmaniasis is one single nosological entity throughout the world, its different clinical forms (cutaneous, mucosal, visceral) merely reflecting the adaptation of the parasite to its environment.
 ...
PMID:[Laryngeal leishmaniasis in a patient from the Jura. Unusual cause of epitheloid and giant cell granulomatosis]. 622 42

66 serum samples from patients suffering from mucocutaneous leishmaniasis (20), Chagas' disease (12), malaria (16) or amebiasis (18) were collected and examined with five different protozoic antigens (L. donovani, T. cruzi, P. fieldi, P. falciparum, E. histolytica) by means of the indirect fluorescent antibody test, the complement fixation test, the indirect hemagglutination test and the latex agglutination. Cross-reactions were observed only between the sera from patients with leishmaniasis and Chagas' disease, both groups, however, showed stronger reactions with the homologous antigen. There were no cross-reactions among the other antigens and antibodies. The results obtained in this study together with facts already proved by literature show the usefulness of the employed antigens for epidemiological surveys.
 ...
PMID:[Immunodiagnostic findings in sera of patients with leishmaniasis, Chagas' disease, malaria and amebiasis in endemic regions of Venezuela (author's transl)]. 628 63

The direct antiglobulin test (DAT) was performed on 243 subjects in Kenya. A high incidence of positive DAT was found in children with malaria of whom 70% had RBCs coated with IgG, C3 and C4 either separately or together. Only 12% of paediatric patients with conditions other than malaria had a positive DAT. Most positive DATs in association with malaria occurred in children between 18 months and five years of age. There was a lower incidence of positive DAT in Kikuyu children from an area of low malarial transmission than in children from other tribal groups who reside in areas of high malaria endemicity. A high rate of positive DAT was also found in patients with visceral leishmaniasis. Interestingly there was an association of IgG and C4 but without C3 on red cells of five patients with visceral leishmaniasis and two schoolchildren from an area endemic for visceral leishmaniasis. This combination was not found on other patients.
 ...
PMID:The coombs direct antiglobulin test in Kenyans. 634 65

Leishmania braziliensis panamensis promastigotes, temperature-induced in vitro-cultivated amastigotes, Vero cell-derived amastigotes, and rodent lesion-derived amastigotes were evaluated as antigens in the indirect immunofluorescent antibody (IFA) test for American cutaneous leishmaniasis. Test sensitivity was determined using sera from 34 U.S. soldiers with leishmaniasis diagnosed by demonstrating parasites in their skin lesions. Sera were collected from 3 to 24 months after exposure to Leishmania. Positive IFA reactions among patient sera were 82% with promastigotes or lesion amastigotes, 79% with in vitro amastigotes, and 76% with Vero cell amastigotes (P = N.S.). Positive titers ranged from 1:8 to 1:128 using all antigens. Test specificity was determined with 30 sera from healthy individuals. False positive reactions ranged from 0-5% depending on the antigen and all titers were less than or equal to 1:8. Test cross-reactivity was assessed with 47 sera from patients with other diseases. Depending on the antigen, cross-reactions occurred with sera from patients with Chagas' disease, lupus erythematosus, malaria, toxoplasmosis and amebiasis. None of the antigens cross-reacted with sera from patients with viral hepatitis, coccidioidomycosis, syphilis, schistosomiasis, and trichinosis. In replicate experiments, 99-100% of the sera varied no more than +/- 1 titer dilution. As sensitivity, specificity, cross-reactivity, and reproducibility of the four antigens were statistically similar, promastigotes, which can be easily and economically cultured in large numbers in vitro are recommended for use in the IFA test for American cutaneous leishmaniasis.
 ...
PMID:Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. 635 6

This review of the immunological diagnosis of parasitic diseases defines the various indications, the means of collection and preparation, the various levels of specificity and the choice of parasitic antigen which should be used for immuno-diagnosis. The detection and assay of circulating antibodies relies on the techniques of immuno-precipitation (immunodiffusion, immunoelectrophoresis, electrosyneresis), indirect agglutination (latex and haemagglutination) or the use of labelled compounds (immunofluorescence, enzymo-immunoassay, radio-immunoassay). Their respective advantages and disadvantages are discussed. The detection and assay of circulating antigens involve the use of agglutination techniques (mycoses), radio-immunoassay or enzymo-immunoassay (protozooses and helminthiases). The authors review the applications of immunological diagnosis for the helminthiases (Trichinosis, Toxocarosis, Filariasis, Anguillosis, Ascaridiasis, Echinococcosis, Taeniasis and Cysticercosis, Distomatosis and Schistosomiasis), the protozoan infections (malaria, Toxoplasmosis, Amebiasis, Trypanosomiasis, Leishmaniasis) and the mycoses (Aspergillosis, Candidiasis, Cryptococcosis). They also discuss the prospects for the development of immunological diagnosis by identification, purification and standardization of parasitic antigens and the study of circulating antigens and idiotypic anti-parasitic antibodies. Finally, they outline the respective responsibilities of the biologist and the prescribing doctor for the proper use of immunological diagnosis of parasitic diseases.
 ...
PMID:[Current methods of immunologic diagnosis in parasitology]. 636

The dot enzyme-linked immunosorbent assay (Dot-ELISA), standard ELISA and the complement fixation (CF) tests were compared in the serodiagnosis of African visceral leishmaniasis (kala-azar). Assay sensitivity was determined using sera from 44 patients with parasitologically confirmed kala-azar. Using the Dot-ELISA, 42 of 44 patients (95%) were positive at a reciprocal titer of greater than or equal to 32 (titer range 512-524 288). In the standard ELISA technique, 43 of 44 patients (98%) were positive (titer range 32-32 768). At a reciprocal titer of greater than or equal to 8 in the CF test, 35 patients (80%) were positive, 1 (2%) was negative and 8 patients (18%) showed anticomplementary (AC) activity (titer range 8-2048). Specificity, determined using 33 sera from healthy individuals not living in endemic areas, was 97% in both the Dot-ELISA and the standard ELISA (32 of 33 sera); in he CF test, all sera were negative except 1 (3%) which showed AC activity. Sera from patients with Chagas' disease cross-reacted in the dot-ELISA up to a titer of 512. In the standard ELISA, cross-reactions occurred mainly using sera from patients with Chagas' disease, malaria and syphilis, and to a lesser extent with sera from amebiasis, schistosomiasis and trichinosis patients. Overall titer agreement in replicate experiments was highest in the Dot-ELISA (89%), followed by the standard ELISA (80%) and the CF test (72%).
 ...
PMID:Dot enzyme-linked immunosorbent assay (Dot-ELISA): comparison with standard ELISA and complement fixation assays for the diagnosis of human visceral leishmaniasis. 643 37


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>